T. Rowe Price Associates’s ProKidney PROK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-43,108
| Closed | -$38K | – | 3129 |
|
|
2025
Q1 | $38K | Buy |
43,108
+2,630
| +6% | +$2.32K | ﹤0.01% | 2957 |
|
|
2024
Q4 | $69K | Buy |
40,478
+5,073
| +14% | +$8.65K | ﹤0.01% | 2883 |
|
|
2024
Q3 | $68K | Buy |
35,405
+16,211
| +84% | +$31.1K | ﹤0.01% | 2887 |
|
|
2024
Q2 | $48K | Buy |
19,194
+8,709
| +83% | +$21.8K | ﹤0.01% | 2861 |
|
|
2024
Q1 | $18K | Hold |
10,485
| – | – | ﹤0.01% | 2931 |
|
|
2023
Q4 | $19K | Buy |
+10,485
| New | +$19K | ﹤0.01% | 2873 |
|
|
2023
Q3 | – | Sell |
-12,501
| Closed | -$140K | – | 2902 |
|
|
2023
Q2 | $140K | Buy |
+12,501
| New | +$140K | ﹤0.01% | 2618 |
|